Patient Guides & FAQ

GLP-1 plateaued? A Chattanooga physician who reads your labs and titrates both HRT and GLP-1 himself explains why one alone stalls.

GLP-1 plateaus are common and explainable. Learn the physiology behind stalled progress and why physician-guided adjustments matter more than switching on your own.

Dr. Paul Miranda explains why GLP-1s alone can plateau after 40, and why Chattanooga needs physician-led GLP-1 + hormone therapy together.

A peptide vendor’s 6-year sentence highlights gray-market risks. Dr. Miranda explains legit vs. illicit sourcing and FDA-approved options in Chattanooga.

Practical, physician-reviewed tips for managing common GLP-1 side effects like GI changes, hunger shifts, and missed doses.

Physician-led bioidentical HRT for Chattanooga women — real lab review, transparent pricing, and the metabolic link most clinics miss.

A physician’s plain-language look at the peptide stacking trend, and what’s actually FDA-approved for weight management vs. what’s still investigational.

HRT in Chattanooga done like real medicine: labs before prescriptions, one named physician on your chart, no flat-tier dosing.

Plateaus on semaglutide or tirzepatide are common. Here’s the clinical reasoning behind slow weeks and why follow-up beats quitting.

BPC-157, HGH, and retatrutide are trending in online peptide communities. Here’s what’s FDA-approved, what isn’t, and why that distinction matters.